Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
DEXKETOPROFEN
PCO Manufacturing
M01AE17
DEXKETOPROFEN
25 Milligram
Film Coated Tablet
Product subject to prescription which may be renewed (B)
Propionic acid derivatives
Authorised
2011-08-12
PACKAGE LEAFLET: INFORMATION FOR THE USER KERAL ® 25 MG TABLETS Dexketoprofen trometamol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Keral is and what it is used for 2. Before you take Keral 3. How to take Keral 4. Possible side effects 5. How to store Keral 6. Further information 1. WHAT KERAL IS AND WHAT IT IS USED FOR Keral is a pain killer from the group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It is used to treat mild to moderate pain, such as muscular pain, painful periods (dysmenorrhoea), toothache. 2. BEFORE YOU TAKE KERAL DO NOT TAKE KERAL: If you are allergic (hypersensitive) to dexketoprofen trometamol or to any of the other ingredients of Keral (see section 6); If you are allergic to acetylsalicylic acid or to other non-steroidal anti-inflammatory medicines; If you have asthma or have suffered attacks of asthma, acute allergic rhinitis (a short period of inflamed lining of the nose), nasal polyps (lumps within the nose due to allergy), urticaria (skin rash), angioedema (swollen face, eyes, lips, or tongue, or respiratory distress) or wheezing in the chest after taking aspirin or other non- steroidal anti-inflammatory medicines; Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Keral 25mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Dexketoprofen trometamol 36.9 mg corresponding to dexketoprofen 25 mg. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated Tablet _Product imported from The United Kingdom:_ White, round, scored film-coated tablets. The tablets can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic treatment of pain of mild to moderate intensity, such as musculo-skeletal pain, dysmenorrhoea, dental pain. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults: According to the nature and severity of pain, the recommended dosage is generally 12.5 mg every 4-6 hours or 25 mg every 8 hours. The total daily dose should not exceed 75 mg. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4, Special warnings and precautions for use). KERAL tablets are not intended for long term use and the treatment must be limited to the symptomatic period. Concomitant administration with food delays the absorption rate of the drug (see section 5.2, Pharmacokinetic Properties), thus in case of acute pain it is recommended that administration is at least 30 minutes before meals. Elderly: In elderly patients it is recommended to start the therapy at the lower end of the dosage range (50 mg total daily dose). The dosage may be increased to that recommended for the general population only after good general tolerance has been ascertained. Hepatic dysfunction: Patients with mild to moderate hepatic dysfunction should start therapy at reduced doses (50 mg total daily dose) and be closely monitored. KER Read the complete document